Skip to content

Impact of Omega-3 supplement on dry eye treatment

Clinical trial comparing the effects of omega-3 supplements and artificial tear drops on dry eye symptoms after surgery, cataract emulsification methods

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013062413567N4
Enrollment
60
Registered
2013-11-01
Start date
2013-08-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye syndrome. Other disorders of lacrimal gland

Interventions

Intervention 1: Intervention group : The first patient with a unique code (1) be given package A (i.e. oral Omega-3 capsules plus Artelac Eye Drops) . Patients need to instil a drop of artificial E
Treatment - Drugs
Placebo
Intervention group : The first patient with a unique code (1) be given package A (i.e. oral Omega-3 capsules plus Artelac Eye Drops) . Patients need to instil a drop of artificial Eye Drops , wit
Control group: The second patient with a unique code (2) be given package B (i.e. Artelac Eye Drops). Patients in the control group need to instil a drop of artificial Eye Drops, with trademark of

Sponsors

Vice chancellor for research, Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The Inclusion criteria: 1-Dry-eye symptoms following Phacoemulsification Cataract Surgery 2-Index of 30 or more from the Ocular Surface Disease Questionnaire 3-The Schirmer test of 10 millimeter or less 4-The Tear Break up Times of 7 seconds or less 5-Lack of eye trauma 6-The absence of uveitis Exclusion criteria: 1-Surgery on eyes including Surgical Correction of Refractive Errors 2-Using contact lenses 3-Systemic diseases which cause dry eye such as Sjogren ,Diabetic Retinopathy and end organ damage disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Eye problems in performing daily. Timepoint: Before intervention-Three months after treatment. Method of measurement: Ocular Surface Disease Index Questionnaire.;Tear break up time. Timepoint: Before intervention-Three months after treatment. Method of measurement: Measured in seconds -With timer and Slit Lamp.;Moisture eye. Timepoint: Before intervention-Three months after treatment. Method of measurement: Schirmer Test -Millimeters.;Visual acuity. Timepoint: Before intervention-Three months after treatment. Method of measurement: Snelen chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Mohammadpour

Tehran University of Medical Sciences

MAHAMMADPOUR@yahoo.com+98 21 5542 1006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026